Cardlytics Proceeds Revenue Contraction Among Deterioration Business Economics (NASDAQ: CDLX)

.Financial writer advises selling Cardlytics, Inc. due to declining unit business economics, earnings problems, as well as negative monetary trends. Click for this CDLX upgrade.